Literature DB >> 6193067

Induction of endotoxin tolerance with nonpyrogenic O-antigenic oligosaccharide-protein conjugates.

A A Lindberg, S E Greisman, S B Svenson.   

Abstract

We prepared a dodecasaccharide, specific for the O-antigenic polysaccharide chain of Salmonella typhimurium (O-antigens 4 and 12), by the partial hydrolysis of the O-polysaccharide chain, utilizing bacteriophage 28B endo-alpha-L-rhamnosidase. The dodecasaccharide was shown by chemical and spectroscopical analyses to be totally devoid of lipid A and core oligosaccharide. By coupling this dodecasaccharide to human serum albumin, a glycoconjugate (DODECA-4809-ITC-HSA) was prepared and found to be (i) nonpyrogenic, (ii) unable to gelate a Limulus amoebocyte lysate, and (iii) unable to induce early-phase pyrogenic tolerance to endotoxin. Rabbits immunized either intravenously (with the glycoconjugate suspended in saline) or intrapopliteally (with the glycoconjugate suspended in Freund complete adjuvant) developed a significant although modest pyrogenic tolerance against challenge with the O-antigenic homologous S. typhimurium lipopolysaccharide (P less than 0.025 and P less than 0.01 for immunized and control rabbits, respectively). The evoked tolerance was O-antigen specific since no pyrogenic tolerance against challenge with lipopolysaccharide from S. thompson (possessing identical lipid A and core oligosaccharide structures but differing in the O-antigen polysaccharide chain) could be seen (P greater than 0.1). These results demonstrate that a nonpyrogenic O-antigenic polysaccharide hapten, when coupled to an immunogenic carrier protein, evokes immune responses which mediate significant, although modest, late-phase tolerance and is capable of partly reducing the pyrogenic activity of the O-antigenic homologous lipopolysaccharide.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193067      PMCID: PMC264584          DOI: 10.1128/iai.41.3.888-895.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Mechanisms of endotoxin tolerance. 8. Specificity of serum transfer.

Authors:  S E Greisman; E J Young; B DuBuy
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

2.  Mechanisms of endotoxin tolerance with special reference to man.

Authors:  S E Greisman; R B Hornick
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

3.  Mechanisms of endotoxin tolerance. V. Specificity of the early and late phases of pyrogenic tolerance.

Authors:  S E Greisman; E J Young; F A Carozza
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

4.  Titration of antibodies to salmonella O antigens by enzyme-linked immunosorbent assay.

Authors:  H E Carlsson; A A Lindberg; S Hammarström
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

Review 5.  Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae.

Authors:  O Lüderitz; A M Staub; O Westphal
Journal:  Bacteriol Rev       Date:  1966-03

6.  Evaluation of some extraction methods for the preparation of bacterial lipopolysaccharides for structural analysis.

Authors:  A A Lindberg; T Holme
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

7.  Relation of structure to function in bacterial endotoxins. VIII. Biological activities in a polysaccharide-rich fraction.

Authors:  A Nowotny; U H Behling; H L Chang
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

8.  Mechanisms of endotoxin tolerance. IV. Specificity of the pyrogenic refractory state during continuous intravenous infusions of endotoxin.

Authors:  S E Greisman; E J Young; W E Woodward
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

9.  Immunochemistry of Salmonella O-antigens: preparation of an octasaccharide-bovine serum albumin immunogen representative of Salmonella serogroup B O-antigen and characterization of the antibody response.

Authors:  S B Svenson; A A Lindberg
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

10.  Lipid A antiserum-mediated protection against lipopolysaccharide- and lipid A-induced fever and skin necrosis.

Authors:  E T Rietschel; C Galanos
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

View more
  11 in total

1.  Some effects of gram-negative bacterial endotoxin and its importance as a contaminator of biological preparations.

Authors:  C R Yagoda; A C Bylund-Fellenius; H Kindahl
Journal:  Acta Vet Scand       Date:  1990       Impact factor: 1.695

2.  [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].

Authors:  E T Rietschel; H Brade
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

3.  [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].

Authors:  E T Rietschel; H Brade
Journal:  Infection       Date:  1987       Impact factor: 3.553

4.  The effect of a bacterial endotoxin or cloprostenol on the clinical status and hormonal levels in 80-100 days pregnant gilts.

Authors:  N Cort; H Kindahl
Journal:  Acta Vet Scand       Date:  1986       Impact factor: 1.695

5.  A caprine experimental model for studies on inflammation.

Authors:  K Persson; G Aström
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

6.  Some reproductive and clinical aspects of endotoxins in cows with special emphasis on the role of prostaglandins.

Authors:  G Fredriksson
Journal:  Acta Vet Scand       Date:  1984       Impact factor: 1.695

7.  Endotoxin-induced abortion in early pregnant gilts and its prevention by flunixin meglumine.

Authors:  N Cort; H Kindahl
Journal:  Acta Vet Scand       Date:  1990       Impact factor: 1.695

8.  Prevention of renal scarring from pyelonephritis in nonhuman primates by vaccination with a synthetic Escherichia coli serotype O8 oligosaccharide-protein conjugate.

Authors:  J A Roberts; M B Kaack; G Baskin; S B Svenson
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.

Authors:  B Hamasur; M Haile; A Pawlowski; U Schroder; G Kallenius; S B Svenson
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

10.  Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.

Authors:  H S Warren; T J Novitsky; A Bucklin; S A Kania; G R Siber
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.